SAM
Simplify Asset Management Portfolio holdings
AUM
$4.93B
1-Year Est. Return
7.16%
1 Year Est. Return
+7.16%
AUM
$1.65B
AUM Growth
-$492M
(-23%)
Holding
110
Top Buys
| 1 | +$28.8M | |
| 2 | +$26.6M | |
| 3 | +$6.47M | |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.2M |
| 5 |
GeneDx Holdings
WGS
|
+$5.23M |
Top Sells
| 1 | +$488M | |
| 2 | +$55.9M | |
| 3 | +$29.8M | |
| 4 |
Simplify US Equity PLUS Upside Convexity ETF
SPUC
|
+$18.8M |
| 5 |
Simplify Intermediate Term Treasury Futures Strategy ETF
TYA
|
+$12.5M |
Sector Composition
| 1 | Healthcare | 7.81% |
| 2 | Energy | 1.5% |
| 3 | Consumer Discretionary | 0.88% |
| 4 | Industrials | 0.66% |
| 5 | Consumer Staples | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cardinal Health
CAH
$49.4B
| $3.89M | 0.2% |
23,229
-27,983
|
|
||
27
Danaher
DHR
$158B
| $3.6M | 0.18% |
18,245
-23,599
|
|
||
28
Fluor
FLR
$6.83B
| $3.5M | 0.18% |
+68,174
|
|
||
29
AbbVie
ABBV
$398B
| $3.41M | 0.17% |
18,384
-2,018
|
|
||
30
CVS Health
CVS
$100B
| $3.24M | 0.16% |
46,966
+37,861
|
|
||
31
Abeona Therapeutics
ABEO
$259M
| $3.17M | 0.16% |
558,584
+150,000
|
|
||
32
Pacira BioSciences
PCRX
$1.02B
| $2.89M | 0.15% |
120,843
-13,199
|
|
||
33
Achieve Life Sciences
ACHV
$248M
| $2.68M | 0.13% |
1,184,512
+966,667
|
|
||
34
Cencora
COR
$69.9B
| $2.62M | 0.13% |
+8,753
|
|
||
35
ResMed
RMD
$36.3B
| $2.58M | 0.13% |
10,005
-1,096
|
|
||
|
LITL
36
Simplify Piper Sandler US Small-Cap PLUS Income ETF
LITL
$5.83M
| $2.53M | 0.13% |
+91,464
|
|
||
37
AstraZeneca
AZN
$281B
| $2.27M | 0.11% |
32,451
-3,539
|
|
||
38
Regeneron Pharmaceuticals
REGN
$78.8B
| $1.94M | 0.1% |
3,697
+939
|
|
||
39
Milestone Pharmaceuticals
MIST
$229M
| $1.92M | 0.1% |
990,000
+140,000
|
|
||
40
GE HealthCare
GEHC
$36.1B
| $1.84M | 0.09% |
+24,776
|
|
||
41
DexCom
DXCM
$24.8B
| $1.8M | 0.09% |
20,650
+1,841
|
|
||
42
Alignment Healthcare
ALHC
$3.82B
| $1.68M | 0.08% |
120,321
-13,145
|
|
||
43
Rithm Capital
RITM
$6.35B
| $1.6M | 0.08% |
142,085
-48,695
|
|
||
44
Insmed
INSM
$45.1B
| $1.56M | 0.08% |
15,536
-5,094
|
|
||
45
Johnson & Johnson
JNJ
$495B
| $1.53M | 0.08% |
10,005
-32,212
|
|
||
46
TScan Therapeutics
TCRX
$57.9M
| $1.52M | 0.08% |
1,046,916
|
|
||
47
Quest Diagnostics
DGX
$20.4B
| $1.47M | 0.07% |
8,161
-12,510
|
|
||
48
Delcath Systems
DCTH
$338M
| $1.45M | 0.07% |
106,629
-10,371
|
|
||
49
Applied Therapeutics
APLT
$34.8M
| $1.4M | 0.07% |
4,487,505
|
|
||
50
Revvity
RVTY
$11.6B
| $1.4M | 0.07% |
14,426
-1,577
|
|